← 產業報告目錄
Interventional Cardiology Devices Market Size, Share & Trends Analysis Report By Product (Angioplasty Balloons, Angioplasty Stents, Structural Heart Devics, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices Other Devices), By Region, And by Segment Forecasts, 2024-2031
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-02-04頁數 180報告編號 INSIGHTACE-3c83640619
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
With a 2023 valuation of USD 18.84 Bn, the global Interventional Cardiology Devices Market is poised to increase to USD 33.91 Bn by 2031, demonstrating a CAGR of 7.75% during the 2024–2031 forecast window.
Interventional Cardiology Devices encompasses needed for interventional procedures to repair weak or damaged vessels, clogged arteries, or other impacted areas of the heart without surgery. The sector has gained traction as organizations seek innovative approaches to address evolving healthcare challenges.
Several factors contribute to this trajectory, including heightened call for next-generation products, expanding applications across diverse end-use sectors, and supportive government initiatives.
The market landscape is structured across several key segments—spanning type, application, distribution channel, and region—each contributing uniquely to overall market expansion.
Regional dynamics show North America and Europe as established hubs, with the Asia-Pacific region poised to deliver the strongest growth trajectory through the forecast period, propelled by demographic shifts and policy support.
Industry participants are deploying a range of strategies—including partnerships, mergers, technological investments, and portfolio diversification—to consolidate their market standing.
Through rigorous analysis of market trends, growth catalysts, restraints, and opportunities, this study offers valuable perspectives for companies, investors, and policymakers navigating this evolving landscape.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Interventional Cardiology Devices Market Snapshot
Chapter 4. Global Interventional Cardiology Devices Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. COVID-19 Impact Analysis
Chapter 5. Market Segmentation 1: By Technology Estimates & Trend Analysis
5.1. By Technology & Market Share, 2023-2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Technology:
5.2.1. Angioplasty Balloons
5.2.1.1. Old/Normal Balloons
5.2.1.2. Drug-eluting Balloons
5.2.1.3. Cutting and Scoring Balloons
5.2.2. Angioplasty Stents
5.2.2.1. Drug-eluting Stents
5.2.2.2. Bare-metal Stents
5.2.2.3. Bioabsorbable Stents
5.2.3. Structural Heart Devics
5.2.3.1. Aortic Valve Therapy Devices
5.2.3.2. Other Therapy Devices
5.2.4. Catheters
5.2.4.1. Angiography Catheters
5.2.4.2. Guiding Catheters
5.2.4.3. IVUS/OCT Catheters
5.2.5. Plaque Modification Devices
5.2.5.1. Atherectomy Devices
5.2.5.2. Thrombectomy Devices
5.2.6. Hemodynamic Flow Alteration Devices
5.2.6.1. Embolic Protection Devices
5.2.6.2. Chronic Total Occlusion Devices
5.2.7. Other Devices
5.2.7.1. Guidewires
5.2.7.2. Vascular Closure Devices
5.2.7.3. Introducer Sheaths
5.2.7.4. Hemostasis Valves
5.2.7.5. Balloon Inflation Devices
Chapter 6. Interventional Cardiology Devices Market Segmentation 2: Regional Estimates & Trend Analysis
6.1. North America
6.1.1. North America Interventional Cardiology Devices Market revenue (US$ Million) estimates and forecasts By Technology, 2019-2031
6.1.2. North America Interventional Cardiology Devices Market revenue (US$ Million) estimates and forecasts by country, 2019-2031
6.1.2.1. U.S.
6.1.2.2. Canada
6.2. Europe
6.2.1. Europe Interventional Cardiology Devices Market revenue (US$ Million) by Technology, 2019-2031
6.2.2. Europe Interventional Cardiology Devices Market revenue (US$ Million) by country, 2019-2031
6.2.2.1. Germany
6.2.2.2. Poland
6.2.2.3. France
6.2.2.4. Italy
6.2.2.5. Spain
6.2.2.6. UK
6.2.2.7. Rest of Europe
6.3. Asia Pacific
6.3.1. Asia Pacific Interventional Cardiology Devices Market revenue (US$ Million) by Technology, 2019-2031
6.3.2. Asia Pacific Interventional Cardiology Devices Market revenue (US$ Million) by country, 2019-2031
6.3.2.1. China
6.3.2.2. India
6.3.2.3. Japan
6.3.2.4. Australia
6.3.2.5. Rest of Asia Pacific
6.4. Latin America
6.4.1. Latin America Interventional Cardiology Devices Market revenue (US$ Million) by Technology, 2019-2031
6.4.2. Latin America Interventional Cardiology Devices Market revenue (US$ Million) by country, (US$ Million) 2019-2031
6.4.2.1. Brazil
6.4.2.2. Rest of Latin America
6.5. Middle East & Africa
6.5.1. Middle East & Africa Interventional Cardiology Devices Market revenue (US$ Million) by Technology, 2019-2031(US$ Million)
6.5.2. Middle East & Africa Interventional Cardiology Devices Market revenue (US$ Million) by country, (US$ Million) 2019-2031
6.5.2.1. South Africa
6.5.2.2. GCC Countries
6.5.2.3. Rest of MEA
Chapter 7. Competitive Landscape
7.1. Major Mergers and Acquisitions/Strategic Alliances
7.2. Company Profiles
7.2.1. Medtronic (US)
7.2.2. Boston Scientific Corporation (US)
7.2.3. Abbott (US)
7.2.4. Edward Lifescinces Corporation (US)
7.2.5. Cardinal Health (US)
7.2.6. iVascular (Spain)
7.2.7. Becton, Dickinson, and Company (US)
7.2.8. B. Braun Melsungen (Germany)
7.2.9. Terumo Corporation (Japan)
7.2.10. Biosensors International Group (Singapore)
7.2.11. BIOTRONIK SE & Co. KG (Germany).
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理,提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們